CHRISTOPHER ZULAWSKI: Open Payments
NPI 1790848489 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,388 in 68 payments from 21 companies in 2025. Trend: 2023 $1,873 · 2024 $1,884 · 2025 $1,388
Food & beverage: $1,388
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $322 |
| PFIZER INC. | 11 | $198 |
| Novartis Pharmaceuticals Corporation | 5 | $99 |
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| Neurelis, Inc. | 4 | $80 |
| LivaNova USA, Inc. | 4 | $71 |
| Amneal Pharmaceuticals LLC | 3 | $70 |
| Lilly USA, LLC | 3 | $69 |
| Lundbeck LLC | 3 | $57 |
| Eisai Inc. | 3 | $54 |
Products named: UBRELVY, NURTEC ODT, KESIMPTA, REXULTI, VALTOCO, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, CREXONT, KISUNLA.
Industry payments across NY — which companies pay providers there.
